Mitsubishi UFJ Trust & Banking
LAB icon

Mitsubishi UFJ Trust & Banking’s Standard BioTools LAB Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,093,313
Closed -$2.78M – 1308
2020
Q1 		$2.78M Buy
+1,093,313
New +$3.59M 0.01% 747

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's LAB Position: Q2 2020 in Review

Mitsubishi UFJ Trust & Banking sold out of Standard BioTools (LAB) in Q2 2020, closing a stake of 1,093,313 shares — an estimated $2.78M sold.

Mitsubishi UFJ Trust & Banking first reported a position in LAB in Q1 2020 and held it in 1 quarter. The position peaked at $2.78M in Q1 2020. 112 funds tracked by Wall St. Rank hold LAB as of Q2 2020.

  • Mitsubishi UFJ Trust & Banking reported no remaining Standard BioTools position as of Q2 2020 after selling out during the quarter.
  • Mitsubishi UFJ Trust & Banking sold 1,093,313 Standard BioTools shares in Q2 2020, an estimated $2.78M.
  • Mitsubishi UFJ Trust & Banking first reported a position in Standard BioTools in Q1 2020 and held it in 1 quarter.
  • Mitsubishi UFJ Trust & Banking's Standard BioTools position peaked at $2.78M in Q1 2020.
  • 112 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2020.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2020, filed 13 Aug 2020.